Abstract
Background: Measuring cognition in clinical practice is clearly essential to the appropriate characterisation of patients’ clinical status and to the development of a personalised care plan. The Screen for Cognitive Impairment in Psychiatry (SCIP) has been developed in order to provide a brief and accessible tool allowing the evaluation of cognitive function in psychiatric conditions. Objective: We present a validation of a French version of the SCIP. Method: Translation from English into French is carried out using the accepted back-translation method. Seventy-two healthy volunteers are characterised by demographic questionnaires and a neuropsychological battery. The French version of the SCIP is then administered on two separate occasions separated by at least a one-week interval. Results: High internal consistencies as well as strong correlations with comparable neuropsychological tests are obtained. A normalised Cronbach’s α = 0.66 is obtained. Conclusions: The French version of the SCIP (SCIP-F) yields results comparable to the English version. The SCIP represents an essential tool for the preliminary evaluation of cognition. Its characteristics, brevity and the lack of need for a technological platform, allow for its integration into clinical practice. Further testing of SCIP-F in various psychiatric conditions will yield valuable information on its potential in clinical settings.
Highlights
The notion that cognitive functions contribute to functional outcomes has become increasingly apparent in various psychiatric disorders
Women showed no significant differences between the 3 versions of the Screen for Cognitive Impairment in Psychiatry (SCIP)
For Verbal Fluency Test (VFT), an effect of version was observed where participants of both genders scored higher in the version 2, but no differences between the sexes were observed
Summary
The notion that cognitive functions contribute to functional outcomes has become increasingly apparent in various psychiatric disorders. Cognitive functioning is classically assessed via comprehensive neuropsychological testing. This mode of assessment remains the gold standard against which other evaluations of cognition are measured. As new data reveals the importance of measuring cognitive functioning in psychiatric disorders, researchers have explored ways in which to screen for putative cognitive deficits, which may guide decision-making as to the necessity for classical methods of assessment of cognition. The Screen for Cognitive Impairment in Psychiatry (SCIP) has been developed in order to provide a brief and accessible tool allowing the evaluation of cognitive function in psychiatric conditions. Further testing of SCIP-F in various psychiatric conditions will yield valuable information on its potential in clinical settings
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
